Study of capsular polysaccharide from Vibrio parahaemolyticus

Infection and Immunity

Volumn 71, Issue 6, 2003, Pages 3329-3336

  Hsieh, Yu Chi ^a   Liang, Shu Mei ^b   Tsai, Wan Ling ^c   Chen, Yee Hsiung ^a   Liu, Teh Yung ^a   Liang, Chi Ming ^a  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; CHOLERA TOXIN; OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIUM ADHERENCE; BACTERIUM CULTURE; CONTROLLED STUDY; CPG ISLAND; CULTURE MEDIUM; EPITHELIUM CELL; FEMALE; FOOD POISONING; GENE SEQUENCE; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; TARGET CELL; VIBRIO PARAHAEMOLYTICUS;

ANIMALS; BACTERIAL ADHESION; BACTERIAL CAPSULES; BACTERIAL VACCINES; CELL LINE; FEMALE; HUMANS; INTESTINES; MICE; MICE, INBRED BALB C; VIBRIO PARAHAEMOLYTICUS;

EID: 0038104785     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.6.3329-3336.2003     Document Type: Article

References (45)

1. Baker, C. J., L. C. Paoletti, M. R. Wessels, H. K. Guttormsen, M. A. Rench, M. E. Hickman, and D. L. Kasper. 1999. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J. Infect. Dis. 179:142-150.
2. Baxendale, H. E., Z. Davis, H. N. White, M. B. Spellerberg, F. K. Stevenson, and D. Goldblatt. 2000. Immunogenetic analysis of the immune response to pneumococcal polysaccharide. Eur. J. Immunol. 30:1214-1223.
3. Burgeot, C., F. B. Gilbert, and B. Poutrel. 2001. Immunopotentiation of Staphylococcus aureus type 5 capsular polysaccharide co-entrapped in liposomes with alpha-toxin. Vaccine 19:2092-2099.
4. Cabral, D. J., and D. M. Small. 1989. Physical chemistry of bile, p. 621-662. In S. G. Schultz, J. G. Forte, and B. R. Bauner (ed.), Handbook of physiology, sect. 6, vol. 3. American Physiology Society, Bethesda, Md.
5. Carruthers, M. M. 1977. In vitro adherence of Kanagawa positive Vibrio parahaemolyticus to epithelial cells. J. Infect. Dis. 136:588-592.
6. Carruthers, M. M., and B. Anderson. 1979. Inhibition by polyanions of adherence by Kanagawa-positive Vibrio parahaemolyticus: a physicochemical effect. J. Infect. Dis. 140:119-122.
7. Chakrabarti, M. K., A. K. Sinha, and T. Biswas. 1991. Adherence of Vibrio parahaemolyticus to rabbit intestinal epithelial cells in vitro. FEMS Microbiol. Lett. 84:113-118.
8. Chiou, C. S., S. Y. Hsu, S. I. Chiu, T. K. Wang, and C. S. Cho. 2000. Vibrio parahaemolyticus serovar O3:K6 as cause of unusually high incidence of food-borne disease outbreaks in Taiwan from 1996 to 1999. J. Clin. Microbiol. 38:4621-4625.
9. Costerton, J. W., R. T. Irvin, and K. J. Cheng. 1981. The role of bacterial surface structures in pathogenesis. Crit. Rev. Microbiol. 3:303-338.
10. Czerkinsky, C., and J. Holmgren. 1995. The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccines. Immunologist 3:97-103.
11. Czerkinsky, C., M. Quiding, K. Eriksson, I. Nordstrom, M. Lakew, C. Weneras, A. Kilander, S. Bjork, A. M. Svennerholm, E. Butcher, and J. Holmgren. 1995. Induction of specific immunity at mucosal surfaces: prospects for vaccine development. Adv. Exp. Med. Biol. 371B:1409-1416.
12. Fattom, A. I., J. Sarwar, L. Basham, S. Ennifar, and R. Naso. 1998. Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines. Infect. Immun. 66:4588-4592.
13. Fink, D. L., B. A. Green, and J. W. St. Geme III. 2002. The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV. Infect. Immun. 70:4902-4907.
14. Fujino, T., Y. Okuno, D. Nakada, A. Aoyama, K. Fukai, T. Mukai, and T. Uebo. 1953. On the bacteriological examination of Shirasu food poisoning. Med. J. Osaka Univ. 4:299-304.
15. Gallichan, W. S., D. C. Johnson, F. L. Graham, and K. L. Rosenthal. 1993. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein. Br. J. Infect. Dis. 168:622-629.
16. Gingras, S. P., and L. V. Howard. 1980. Adherence of Vibrio parahaemolyticus. Appl. Environ. Microbiol. 39:369-371.
17. Gotschlich, E. C., B. A. Fraser, O. Nishimura, J. B. Robbins, and T.-Y. Liu. 1981. Lipid on capsular polysaccharides of gram-negative bacteria. J. Biol. Chem. 256:8915-8921.
18. Gupta, R. K., and G. R. Siber. 1995. Adjuvants for human vaccines: current status, problems and future prospects. Vaccine 13:1263-1276.
19. Honda, T., and T. Iida. 1993. The pathogenicity of Vibrio parahaemolyticus and the role of the thermostable direct haemolysin and related haemolysins. Rev. Med. Microbiol. 4:106-113.
20. Horner, A. A., and E. Raz. 2000. Immunostimulatory sequence oligodeoxynucleotide: a novel mucosal adjuvant. Clin. Immunol. 95:S19-S29.
21. Hunolstein, C., S. Mariotti, R. Teloni, G. Alfarone, G. Romagnoli, G. Orefici, and R. Nisini. 2001. The adjuvant effect of synthetic oligodeoxynucleotide containing CpG motif converts the anti-Haemophilus influenzae type b glycoconjugates into efficient anti-polysaccharide and anti-carrier polyvalent vaccines. Vaccine 19:3058-3066.
22. Iguchi, T., S. Kondo, and K. Hisatsune. 1995. Vibrio parahaemolyticus O serotypes from O1 to O13 all produce R-type lipopolysaccharide: SD-SPAGE and compositional sugar analysis. FEMS Microbiol. Lett. 130:287-292.
23. Jann, K., and B. Jann. 1992. Capsules of Escherichia coli, expression and biological significance. Can. J. Microbiol. 38:705-710.
24. Kasper, D. L., L. C. Paoletti, M. R. Wessels, H. K. Guttormsen, V. J. Carey, H. J. Jennings, and C. J. Baker. 1996. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugated vaccine. J. Clin. Investig. 98:2308-2314.
25. Kasper, D. L., A. Weintraub, A. A. Lindberg, and J. Lonngren. 1983. Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. J. Bacteriol. 153:991-997.
26. Katoh, H. 1965. Studies on the growth rate of various food bacteria. 3. The growth of V. parahaemolyticus in raw fish meat. Nippon Saikingaku Zasshi 20:541-544.
27. Kauppi, M., L. Saarinen, and H. Kayhty. 1993. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. J. Infect. Dis. 167:365-371.
28. Kotloff, K. L., A. Fattom, L. Basham, A. Hawwari, S. Karkonen, and R. Edelman. 1996. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults. Vaccine 14:446-450.
29. McCluskie, M. J., R. D. Weeratna, J. D. Clements, and H. L. Davis. 2001. Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants. Vaccine 19:3759-3768.
30. Nakasone, N., and M. Ianaga. 1990. Pili of a Vibrio parahaemolyticus strain as a possible colonization factor. Infect. Immun. 58:61-69.
31. Nielsen, K. H., L. Kelly, D. Gall, P. Nicoletti, and W. Kelly. 1995. Improved competitive enzyme immunoassay for the diagnosis of bovine brucellosis. Vet. Immunol. Immunopathol. 46:285-291.
32. Pace, J. L., T. J. Chai, H. A. Rossi, and X. Jiang. 1997. Effect of bile on Vibrio parahaemolyticus. Appl. Environ. Microbiol. 63:2372-2377.
33. Shaffer, E. A., P. McOrmond, and H. Duggan. 1980. Quantitative cholescintigraphy: assessment of gallbladder filling and emptying and duodenogastric reflux. Gastroenterology 79:899-906.
34. Shen, X., T. Lagergard, Y. Yang, M. Lindblad, M. Fredriksson, G. Wallerstrom, and J. Holmgren. 2001. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate. Vaccine 19:3360-3368.
35. St. Geme, J. W., III, M. L. de la Morena, and S. Falkow. 1994. A Haemophilus influenzae IgA protease-like protein promotes intimate interaction with human epithelial cells. Mol. Microbiol. 14:217-233.
36. Takeda, Y. 1982. Thermostable direct hemolysin of Vibrio parahaemolyticus. Pharmacol. Ther. 19:123-146.
37. van Faassen, A., M. J. Hazen, P. A. van den Brandt, A. E. van den Bogaaard, R. J. J. Hermus, and R. A. Janknegt. 1993. Bile acids and pH values in total feces and in fecal water from habitually omnivorous and vegetarian subjects. Am. J. Clin. Nutr. 58:917-922.
38. Waldor, M. K., R. R. Colwell, and J. J. Mekalanos. 1994. The Vibrio cholerae 0139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Proc. Natl. Acad. Sci. USA 91:11388-11392.
39. Wang, T. K., S. I. Ho, J. L. Tsai, and T. M. Pan. 1996. K-serotype analyses of Vibrio parahaemolyticus isolated in northern Taiwan, 1983 through 1993. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 29:210-224.
40. Winkeistein, A., and P. W. Aschner. 1926. The mechanism of the flow of bile from the liver into the intestines. Am. J. Med. Sci, 171:104-111.
41. Wong, H. C., K. T. Lu, T. M. Pan, C. L. Lee, and D. Y. C. Shih. 1996. Subspecies typing of Vibrio parahaemolyticus by pulsed-field gel electrophoresis. J. Clin. Microbiol. 34:1535-1539.
42. Wong, H. C., S. H. Liu, L. W. Ku, I. Y. Lee, T. K. Wang, Y. S. Lee, C. L. Lee, L. P. Kuo, and D. Y. Shih. 2000. Characterization of Vibrio parahaemolyticus isolates obtained from food born illness outbreaks during 1992 through 1995 in Taiwan. J. Food Prot. 63:900-906.
43. Yamamoto, T., and T. Yokota. 1989. Adherence targets of Vibrio parahaemolyticus in human small intestines. Infect. Immun. 57:2410-2419.
44. Yamamoto, T., K. Fujita, and T. Yokota. 1990. Piliated Vibrio parahaemolyticus adherent to human ureteral mucosa. J. Infect. Dis. 161:361-362.
45. Yamamoto, T., M. J. Albert, and R. B. Sack. 1994. Adherence to human small intestines of capsulated Vibrio cholerae O139. FEMS Microbiol. Lett. 119:229-235.